Darlene Dobkowski, MA

December 14, 2021

Tisagenlecleucel evoked similar efficacy and a preferrable safety profile in children and adults with B-ALL being treated in a real-world analysis, compared with the clinical trial ELIANA.

December 12, 2021

Findings presented at the 2021 San Antonio Breast Cancer Symposium suggest that Certain adverse effects associated with olaparib were minimal and resolved with appropriate management in patients with breast cancer.

September 18, 2021

Characteristics such as low positive PD-L1 expression and rare high positive staining were identified in both patients with VHL-mutated and VHL wild type clear cell renal cell carcinoma.

September 13, 2021

Due to the favorable efficacy and safety profiles of daratumumab plus lenalidomide and dexamethasone, researchers speculate that the combination may become the new standard of care in multiple myeloma treatment.

September 12, 2021

Patients with myeloma and a negative MRD may be at a reduced risk of mortality and other progression-free survival events.

June 15, 2021

Amanpour, who is CNN's chief international anchor, announced her diagnosis live on-air, while advocating for cancer screening, too.

June 14, 2021

CURE Media Group also recognized Jennifer E. Giovanni, PhD, MSN, MPH, RN, as winner of the Finest Hour Award, which highlights the dedi- cation and selflessness exhibited in frontline workers during the COVID-19 pandemic.

May 21, 2021

States without Medicaid expansion tended to have poorer cancer outcomes than states with higher income limits on eligibility, according to recent research.

April 20, 2021

A clinic for patients with a history of cancer led by an advanced practice nurse and a dietician may empower patients to improve their lifestyles through diet and exercise, especially since it may have an impact on their outcomes and future risk for diseases.

January 31, 2021

Although survivors and patients with lung cancer felt that they were involved in the treatment decision-making process, nearly half of them reported that they knew what their treatment options were before making a decision, according to results from a study presented at the 2020 World Conference on Lung Cancer Singapore.